Home > Courses > Antiretroviral Chemoprophylaxis

Antiretroviral Chemoprophylaxis

Antiretroviral Chemoprophylaxis
Sorry, this learning module is not available for mobile devices.
This video is available at the Physicians Research Network website.

Original Release Date: 3/15/2011
Review Date: 3/15/2011
  • Kenneth Mayer, MD
    Professor of Medicine and Community Health
    Brown University
Learning Objectives / Desired Outcomes
At the completion of this educational activity, participants will:
  1. Understand how oral antiretroviral agents may be used for pre- and post-exposure prophylaxis.
  2. Understand how topical antiretroviral agents may be used as microbicides to prevent HIV transmission.
  3. Understand the recent results of the CAPRISA 004 and iPrEx efficacy trials, and learn about upcoming chemoprophylaxis trials, and when their results will be known.
  4. Learn about the possibility of using novel antiretroviral agents for chemoprophylaxis.
Presenter Bio
Kenneth Mayer, MD
Kenneth Mayer, MD, is Professor of Medicine and Community Health at Brown University, Director of the Brown University AIDS Program, and Attending Physician in the Infectious Diseases Division of the Miriam Hospital in Providence, Rhode Island; and Medical Research Director at Boston's Fenway Community Health Center, where (since 1983) he has conducted studies of HIV's natural history and transmission. He has co-authored over 400 articles, chapters and other publications on AIDS and related infectious disease topics, and is a frequent lecturer and presenter at national and international conferences and symposia.
PRN Learning Modules